Veeva Systems Inc Class A Stock News

Veeva to deliver next generation customer engagement with agentic AI for Roche PLEASANTON, Calif. , Nov. 24, 2025 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) today announced that Roche Pharmaceuticals has chosen to extend its partnership with Veeva Systems by adopting Veeva Vault CRM.

Veeva Systems (VEEV) reported strong Q3 results, but slowing growth and declining ROIC raise concerns about its competitive edge and valuation. VEEV's robust balance sheet and industry specialization remain strengths, yet customer migration issues and weak guidance signal potential challenges ahead. Despite trading at a historically low PE multiple, the current valuation appears too high given ...

Markets were broadly higher on Friday as investors grew more confident following Thursday's sharp declines. Cava and WillScot Holdings were among the top gainers.

Earnings call commentary overshadows the software company's fiscal-year guidance boost.

Veeva Systems Inc. ( VEEV ) Q3 2026 Earnings Call November 20, 2025 5:00 PM EST Company Participants Gunnar Hansen - Director of Investor Relations Peter Gassner - Founder, CEO & Director Brian Van Wagener - Chief Financial Officer Paul Shawah - Executive Vice President of Strategy & Campaign Manager Conference Call Participants Saket Kalia - Barclays Bank PLC, Research Division Joseph Vruwink ...

Total Revenues of $811.2M, up 16% Year Over Year Subscription Services Revenues of $682.5M, up 17% Year Over Year PLEASANTON, Calif. , Nov. 20, 2025 /PRNewswire/ -- Veeva Systems Inc. (NYSE: VEEV), a leading provider of industry cloud solutions for the global life sciences industry, today announced results for its third quarter ended October 31, 2025.

These two growth stocks have outperformed the market this year. They are leaders in their niches and benefit from competitive advantages.

New applications include Veeva LIMS Basics and PromoMats Basics to drive speed and growth PLEASANTON, Calif. , Nov. 4, 2025 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) today announced that more than 100 biotechs have selected Veeva Basics to advance operations across clinical, regulatory, and quality.